瑞博生物技术股份有限公司 focuses on the research and development of small nucleic acid drug delivery technologies and chemical modifications. It has established a drug development platform that integrates various technologies for small nucleic acids, supporting the lifecycle from early research to industrialization.

瑞博生物技术股份有限公司

Suzhou Ribo Life Science Co., Ltd | 356 followers on LinkedIn. Dedicated to Innovative Oligonucleotide Therapeutics to Improve Human Health and Wellbeing | Established in 2007, Suzhou Ribo Life Science Co., Ltd. (Ribo) is a clinical stage company devoted to the development of innovative RNAi technologies  and oligonucleotide therapeutics as an effort to address unmet clinical needs in the world with the tools, capacity and RNA therapeutics that we build up in China. Fueled by our mission to make China&#39;s oligonucleotide therapeutics serve the world, we seek.

CHINA HEALTHCARE BUSINESS DEVELOPMENT ASSOCIATION

Sam Ma

Suzhou Ribo Life Science Ltd. - VP

Shan Gao

Vice President

Hong Yu

Finance Controller at Suzhou Ribo Life Science Co.,Ltd

Jane Gu

Suzhou Ribo Life Science Co., Ltd

Great mielstone to step into rare disease!

Ribo and Qilu Announce Licensing Agreement for siRNA Therapeutic Targeting PCSK9

We are very pleased to announce this strategic collaboration, leveraging our innovative siRNA technology platform to deliver next-generation treatments for patients with liver diseases.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 5:36 AM	74ceaeb8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 5:36 AM	646386b1
crunchbase trigger	general	Nov 27, 2024 12:50 PM	e11713fd
crunchbase profile	general
li profile	general	Nov 12, 2024 5:36 AM	4aa8254d
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 5:36 AM	40e7160f
news basic	general	Nov 12, 2024 5:36 AM	228d5a0e
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

RIBO

COM:RIBOLIA

瑞博生物技术股份有限公司